Digital Checkup (630)

That's the picture painted by Dr. Bruce Darrow, the interim chief digital and information officer and CMIO, who offers an overview of artificial intelligence used at the famed New York health system today.

Susan Conover, cofounder and CEO of Piction Health, highlights the digital health company’s AI-enabled dermatology-focused offering, its recent $6 million raise and its plan to scale its reach and expand its partnerships across healthcare.

Being able to deliver a "single source of truth" freed up a surgery schedule that was 90% blocked, says Mindy Bosanek, director of Surgical Services and Cynthia Harms, perioperative business manager at Children's Nebraska.

Real-time prescription-benefit data has had a dramatic impact, with patients notably saving money on medication and picking up 8% more scripts, say Dr. Nele Jessel, athenahealth's CMO and Dr. Andrew Mellin, Surescripts' VP and CMIO.

Sean Sullivan, a partner at Alston & Bird, says revised interoperability rules that may drop in June could shed light on reasonable fees and exceptions, details on sensitive information sharing and public health IT certification requirements.

There’s a lot of cash ready to deploy but private equity buyers need sellers who have realistic value expectations, says Aytan Dahukey, partner and leader of Sheppard Mullin’s private equity team.

Cole Wiser, executive creative director and partner at The Virtual Wild, and Srini Iyer, SVP and chief technology officer for Leidos' health and civil sector, discuss using holograms and extended reality for patient engagement and training.

CIO Craig Kwiatkowski offers a look at the AI tools at the famous health system, how its AI-powered primary care app is training AI on data sets that reflect diverse populations, and how he measures the success of AI-enabled initiative.

Craig Kwiatkowski also discusses whether to build or buy AI, and how patients and clinicians are responding to these tools.

MA plans will need to measure performance ahead of 2027 when CMS will start rewarding plans that demonstrate progress in addressing health disparities, says Anna Basevich, SVP of Enterprise Partnerships and Customer Enablement at Arcadia.

The model allows for a gradual approach to risk for more conservative and less experienced ACOs, in comparison to ACO REACH, which requires a greater tolerance for risk but has more rewards, says David Morris, EVP at Cedar Gate Technologies.

Combining clinical data and mathematical models can increase precision and expedite treatment plans. Thierry Marchal of Ansys and researcher María Angeles Pérez discuss its use in pediatric abdominal cancer and across specialties.